Evaluation of hemocompatibility is an important issue in the overall assessment of the safety of nanomedicines, since the administered nanoscale materials enter the bloodstream and interact with blood plasma proteins, erythrocytes, leukocytes, platelets, and endothelial cells
Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a highly selective thyroid hormone receptor agonist in clinical trials for the treatment of dyslipidemia
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Hefeng Huang ([email protected])
So excited
Patient Screening and Intake Before the first infusion, complete a thorough medical history review